Kevin A. Strauss, MD

Head of Therapeutic Development

Kevin Adams Strauss, MD joined the Clinic as a Pediatrician in 2001 and was promoted as the Clinic’s Medical Director in 2008. In 2024, Dr. Strauss became the Clinic’s first Head of Therapeutic Development. As the Clinic’s Head of Therapeutic Development, he leads collaborative work to develop new life-changing therapies for disorders that commonly afflict people of Plain ancestry, serves as a key opinion leader to advance therapeutic research efforts locally and abroad, and mentors Clinic staff in the design, execution, and publication of clinical research.

Dr. Strauss has served as a Principal Investigator on several industry-sponsored and investigator-initiated clinical studies to identify disease-modifying therapies for spinal muscular atrophy, phenylketonuria (PKU), Crigler-Najjar syndrome, and more. Dr. Strauss has co-authored over 80 peer-reviewed journal articles and given over 65 lectures about medical, scientific, and cultural issues all across the globe.

Why are you passionate about working for the Clinic?

I have the best job in the world. Every day I meet with families and I help them through difficult times. Sometimes I can offer a cure, sometimes a specific diagnosis, sometimes I can only offer sincere advice, but I can always reduce or prevent suffering for a child.

 

Dr. Strauss’ Credentials

Education and Certifications

  • Board certified in Pediatrics by American Board of Pediatrics
  • 2001  Boston Combined Residency in Pediatrics, Resident in Pediatrics
  • 1998  Harvard Medical School, Doctor of Medicine
  • 1990  Colgate University, Bachelor of Arts in Biology

Professional Associations

  • American Academy of Pediatrics, Fellow
  • American Board of Pediatrics, Member
  • American Society of Gene and Cell Therapy, Member
  • Society of Inherited Metabolic Disorders, Member
  • Aspa Therapeutics, AAV-mediated gene therapy for Canavan Disease, Data Safety Monitoring Committee
  • CoA Therapeutics, Scientific Advisory Board Member
  • DDX3X Foundation, Scientific Advisory Board Member
  • FNIH-FDA-NIH Accelerated Medicines Program, Bespoke Gene Therapy Consortium, Clinical Task Force
  • MSUD Family Support Group, Scientific Advisory Board Member
  • Nemours/A.I. duPont Hospital for Children, Staff Physician
  • Penn Medicine Lancaster General Health, Staff Physician
  • University of Massachusetts School of Medicine, Adjunct Associate Professor, Department of Pediatrics; Department of Molecular, Cell & Cancer Biology
    • Investigator, Horae Gene Therapy Center
    • Investigator, Li Weibo Institute for Rare Diseases Research

Awards

  • 2020 Rare Impact Award, National Organization for Rare Disorders
  • 2018 Physician Achievement Award: Science and Innovation, Penn Medicine Lancaster General Hospital
  • 2018 Community Star, National Organization of State Offices of Rural Health
  • 2013 Bock Prize for Innovation in Developmental Disabilities Research, Nemours/A.I. duPont Hospital for Children
  • Michael Osband Memorial Award for Excellence in Clinical Research
  • Medical Student Education Committee Award for Teaching Excellence
  • Senior Resident Teaching Award
  • The New England Pediatric Society Prize

Published Papers

To view Dr. Strauss’ peer reviewed published papers, please visit our Published Papers page HERE.